Koch Cancer Research Building, Room 544, 1550 Orleans St., Baltimore, MD 21231, e-mail: at jhmi.edu Rudin To assess the determinants of pharmacogenomics and pharmacokinetics of rash and diarrhea, the two main toxicities. dose-limiting factor receptor (EGFR) tyrosine kinase erlotinib PATIENTS AND METHODS: In a prospective clinical study of 80 cancer patients with non-small cell lung, head and where can I order soma generic Springfield neck cancer and ovarian cancer was performed. Detailed pharmacokinetics and toxicity of erlotinib were evaluated. Polymorphic loci in EGFR, ABCG2, where can I order soma generic Springfield CYP3A4, CYP3A5 and genotype, and their effects on the pharmacokinetics and toxicity were evaluated. Results: A novel diplotypes of two polymorphic loci in the ABCG2 promoter involving-15622C / T and 1143C / T has been identified, with alleles conferring lower ABCG2 levels associated with pharmacokinetic parameters, including where can I order soma generic Springfield erlotinib higher AUC (p = 0.019) and maximum concentration (P = 0.006). The variability of rash was best explained by a logistic regression model that where can I order soma generic Springfield incorporates trough plasma concentrations of erlotinib (P = 0.034) and EGFR intron 1 polymorphism (P = 0.044). Variability in diarrhea was associated with two polymorphisms in the promoter of the EGFR (P 0.01) but not with erlotinib concentration Conclusion. Although exploratory in nature, where can I order soma generic Springfield this combined pharmacogenomic and pharmacokinetic model helps to define and differentiate the major determinants of the skin and gastrointestinal toxicity of erlotinib. The results can be useful both in designing trials targeting a particular where can I order soma generic Springfield severity of the rash and in considering changes to the dose and schedule of the patients experienced dose limiting toxicities of erlotinib or similarly targeted agents. Further studies on the relationship between germline polymorphisms in EGFR and the toxicity and efficacy of EGFR inhibitors are warranted. Erlotinib is the only epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor currently approved where can I order soma generic Springfield for marketing in the United States. The most common side effects of erlotinib where can I order soma generic Springfield include rash diarrhea.1-3 and two of these toxicities can be severe and where can I order soma generic Springfield can lead to discontinuation of treatment.
A strong association, but some unexplained rashes and survival was observed in patients receiving erlotinib for various epithelial cancers, including lung cancer, head and neck, ovarian and cancer3 Interestingly, the toxicity spectrum and the association between the clinical benefit and rash where can I order soma generic Springfield were observed in all classes of EGFR inhibitors. Rash and diarrhea associated with the EGFR inhibitor use both show great where can I order soma generic Springfield variability. Several possible explanations for this observation have been proposed, including pharmacodynamic and pharmacokinetic (PK) variability.4, 5 Identify the where can I order soma generic Springfield determinants of variability can give you a basic idea guiding the design of future clinical research in defining rational strategies for maximize benefits and minimize the clinical effects in patients treated with these agents. Germline polymorphisms may have a significant effect on the pharmacokinetics of the where can I order soma generic Springfield drug and pharmacodynamics.6 EGFR, which encodes where can I order soma generic Springfield a direct target of erlotinib is polymorphic.7, 8 A polymorphism in intron is microsatellitesassociésthe expression of EGFR, with the where can I order soma generic Springfield repeat length of the cytosine-adenosine (CA) nucleótidosinversamente correlated with EGFR mRNA and protein, and sensitivity to erlotinib in vitro.9-12 There are differences marked ethnic intronic locus.
7 More recent studies have identified single nucleotide polymorphisms (SNPs) in the 5 'regulatory EGFR. Two-216g / T (rs712829) and-191C / A (rs712830) are in the essential promoter region of EGFR. The variant-216g / T was associated with increased activity and EGFR promoter gene expression where can I order soma generic Springfield mediated by an altered interaction with SP1, while the 191C / A is close to a major transcription initiation sites.8 recently - 216g / T were reported to be associated with gefitinib response where can I order soma generic Springfield and toxicity in lung cancer patients.13 A nonsynonymous SNP at codon 497 of EGFR (rs11543848), a G to a disturbance, resulting in the substitution amino Arg (R) Lys (K) .14 Only the missense polymorphism of EGFR common reported to where can I order soma generic Springfield date, and the K allele appears to decrease the activity of these polymorphisms EGFR.15 if they are involved in the mechanism underlying side effects and response to tyrosine kinase inhibitors (CCI) in patients with cancer is not yet understood.
ليست هناك تعليقات:
إرسال تعليق